Edwards Lifesciences CVP Daniel J. Lippis Buys and Sells Shares at $59.26 and $85.7 per Share

Edwards Lifesciences Corporation (EW) has announced that Daniel J. Lippis, Chief Value Portfolio and TAVR Officer, has made a transaction involving the purchase and sale of shares. On January 9, 2026, Lippis acquired 1,019 shares at a price of $59.26 per share, and subsequently sold the same number of shares at a price of $85.70 per share on the same day.